CG Carlyle Group Inc (The)
1,881
$42.37
$0.89
(2.15%)
| Watchers | 1,881 |
| 52-Wk Low | $25.67 |
| 52-Wk High | $48.52 |
| Market Cap | $14.9B |
| Volume | 1.19M |
| 52-Wk High | $48.52 |
| 52-Wk Low | $25.67 |
Carlyle Credit Income Fund Schedules Second Quarter 2024 Financial Results and Investor Conference CallPR Newswire • 9 days ago
Carlyle Credit Income Fund Schedules Second Quarter 2024 Financial Results and Investor Conference Call Carlyle Credit Income Fund Schedules Second Quarter 2024 Financial Results and Investor...
Share to Feed
American Century Companies Inc. trimmed its holdings in shares of The Carlyle Group Inc. (NASDAQ:CG Free Report) by 25.2% in the third quarter, according to its most recent filing with the...
Grant Christie Joins Acentra Health
Acentra Health, a Virginia-based technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate...
Public Employees Retirement System of Ohio trimmed its position in The Carlyle Group Inc. (NASDAQ:CG Free Report) by 7.9% during the 3rd quarter, according to the company in its most recent...
BMO and Carlyle Partner to Launch a Private Equity Strategy for Canada BMO and Carlyle Partner to Launch a Private Equity Strategy for Canada Canada NewsWire TORONTO, March 22, 2024 /NOT FOR...
Gotham Asset Management LLC lowered its stake in shares of The Carlyle Group Inc. (NASDAQ:CG Free Report) by 1.4% in the 3rd quarter, according to its most recent Form 13F filing with the...
Treasurer of the State of North Carolina lifted its position in The Carlyle Group Inc. (NASDAQ:CG Free Report) by 0.5% in the third quarter, according to its most recent Form 13F filing with...
NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ( CSL ) (NASDAQ: CGBD) today announced that Justin Plouffe has been named President, Chief Executive Officer (CEO), and...
The Carlyle Group Inc. (NASDAQ:CG Free Report) Stock analysts at Zacks Research dropped their Q1 2024 earnings per share estimates for The Carlyle Group in a research note issued on...
London, UK and New York, USA, February 29, 2024 - Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today announced a strategic...